OPL
LYEL icon

Orland Properties Ltd’s Lyell Immunopharma LYEL Stock Holding History

Orland Properties Ltd’s Portfolio LYEL Stock Details LYEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$15.1M Hold
754,698
– – 5.67% 3
2025
Q4 		$23.2M Hold
754,698
– – 4.35% 3
2025
Q3 		$12.3M Hold
754,698
– – 2.62% 5
2025
Q2 		$6.67M Hold
754,698
– – 2.83% 6
2025
Q1 		$8.15M Hold
754,698
– – 9.84% 5
2024
Q4 		$9.66M Hold
754,698
– – 14.08% 5
2024
Q3 		$20.8M Hold
754,698
– – 13.96% 3
2024
Q2 		$21.9M Hold
754,698
– – 16.63% 3
2024
Q1 		$33.7M Hold
754,698
– – 19.02% 1
2023
Q4 		$29.3M Hold
754,698
– – 14.3% 2
2023
Q3 		$22.2M Hold
754,698
– – 11.75% 3
2023
Q2 		$48M Hold
754,698
– – 24.81% 2
2023
Q1 		$35.6M Hold
754,698
– – 18.69% 2
2022
Q4 		$52.4M Buy
+754,698
New +$75M 27.91% 1

Other funds holding LYEL

AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
GP
GSK plc London $599M AUM
FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return
FCMV
Foresite Capital Management V Larkspur, California $271M AUM 309.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return

Orland Properties Ltd's LYEL Position: Q1 2026 in Review

Orland Properties Ltd held its Lyell Immunopharma (LYEL) position steady in Q1 2026 at 754,698 shares worth $15.1M. The position accounts for 5.67% of the portfolio, ranked #3.

Orland Properties Ltd first reported a position in LYEL in Q4 2022 and has held it in 14 quarters since. The position peaked at $52.4M in Q4 2022. 74 funds tracked by Wall St. Rank hold LYEL as of Q1 2026.

  • Orland Properties Ltd held 754,698 shares of Lyell Immunopharma worth $15.1M as of Q1 2026.
  • Orland Properties Ltd left its Lyell Immunopharma share count unchanged in Q1 2026.
  • Lyell Immunopharma made up 5.67% of Orland Properties Ltd's portfolio in Q1 2026, its #3 holding.
  • Orland Properties Ltd first reported a position in Lyell Immunopharma in Q4 2022 and has held it in 14 quarters since.
  • Orland Properties Ltd's Lyell Immunopharma position peaked at $52.4M in Q4 2022.
  • 74 funds tracked by Wall St. Rank held Lyell Immunopharma as of Q1 2026.

Based on Orland Properties Ltd's 13F filing for Q1 2026, filed 6 May 2026.